Invesco India Pharma and Healthcare Fund vs Mirae Asset Nifty 500 Healthcare ETF
Direct Plan where a fund has one, Growth option · Data as on 30-10-2026
Invesco India Pharma and Healthcare Fund is a Sectoral fund and Mirae Asset Nifty 500 Healthcare ETF is an ETF fund. Invesco India Pharma and Healthcare Fund charges 3.30% a year and Mirae Asset Nifty 500 Healthcare ETF 0.35%. Their portfolios overlap 41.1%: they hold 10 of the same securities.
Invesco India Pharma and Healthcare Fund
Sectoral
- Expense ratio
- 3.30%
- NAV
- ₹9.66
Mirae Asset Nifty 500 Healthcare ETF
ETF
- Expense ratio
- 0.35%
- NAV
- ₹21.44
Which is better, Invesco India Pharma and Healthcare or Mirae Asset Nifty 500 Healthcare ETF? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Mirae Asset Nifty 500 Healthcare ETF costs less: 0.35% a year against 3.30%.
- Mirae Asset Nifty 500 Healthcare ETF fell less in its worst fall since 10-09-2026: −9.6% against −11.4%.
- Invesco India Pharma and Healthcare is the larger fund: ₹436 Cr against ₹15 Cr.
- Their portfolios overlap 41.1%: 10 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Invesco India Pharma and Healthcare Fund | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Fund house | Invesco Mutual Fund | Mirae Asset Mutual Fund |
| Category | Sectoral | ETF |
| AUM | ₹436 Cr (30-09-2026) | ₹15 Cr (30-09-2026) |
| NAV | ₹9.66 (Direct) | ₹21.44 |
| Expense ratio (Direct) | 3.30% | Not available |
| Expense ratio (Regular) | 5.19% | Not available |
| Riskometer | Very High | Very High |
| Benchmark | BSE Healthcare TRI | Nifty500 Healthcare TRI |
| Launch date | 01-09-2026 | Not available |
| Minimum investment | Not available | On exchange in multiple of 1 unit. With AMC: In multiples of 5,000 units |
| Lock in | None | None |
| Fund managers | Aditya Khemani | Ekta Gala, amp, Ritesh Patel |
| Exit load | Exit load of 0.50%, if redeemed within 3 months. | NIL |
Invesco India Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Invesco India Pharma and Healthcare Fund (Direct) | +0.73% | -- | -- | -- | -- | -- | -- |
| Mirae Asset Nifty 500 Healthcare ETF | +1.43% | −0.66% | +12.95% | -- | -- | -- | -- |
| Sectoral average | −1.70% | -- | -- | -- | -- | -- | -- |
Category average: the average of the 20 Sectoral funds, same plan type.
Invesco India Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of Invesco India Pharma and Healthcare Fund
Invesco India Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Invesco India Pharma and Healthcare Fund (Direct) | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Return (CAGR) | −23.45% | +23.46% |
| Standard deviation | 18.70% | 14.16% |
| Sharpe ratio | -1.54 | 1.29 |
| Sortino ratio | -2.20 | 1.90 |
| Maximum drawdown | −11.4% (23-10-2026) | −9.6% (23-10-2026) |
| Beta | 1.00 | 1.00 |
| Alpha | −8.00% | −0.22% |
From daily NAVs, 10-09-2026 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Invesco India Pharma and Healthcare Fund (Direct)
Mirae Asset Nifty 500 Healthcare ETF
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Invesco India Pharma and Healthcare Fund (Direct) | −11.4% | 23-09-2026 | 23-10-2026 | Not yet | -- | −4.4% |
| Mirae Asset Nifty 500 Healthcare ETF | −9.6% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.0% |
| BSE Healthcare TRI | −9.9% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.8% |
From daily values since 10-09-2026, the first day every fund has.
Invesco India Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Portfolio Overlap
From each fund's latest monthly portfolio: Invesco India Pharma and Healthcare Fund, September 2026; Mirae Asset Nifty 500 Healthcare ETF, September 2026
Holdings in common
- Overlap
- 41.1%
- Held by both
- 10
- Only in Invesco India Pharma and Healthcare
- 3
- Only in Mirae Asset Nifty 500 Healthcare ETF
- 34
| Security | % of Invesco India Pharma and Healthcare | % of Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 8.99% | 10.13% |
| Divi's Laboratories Limited | 7.85% | 8.76% |
| Apollo Hospitals Enterprise Limited | 8.03% | 6.24% |
| Max Healthcare Institute Limited | 9.58% | 5.13% |
| Torrent Pharmaceuticals Limited | 4.93% | 5.24% |
| Glenmark Pharmaceuticals Limited | 4.86% | 2.61% |
| Sai Life Sciences Limited | 8.63% | 1.56% |
| Krishna Institute Of Medical Sciences Limited | 4.72% | 1.48% |
| Aster DM Quality Care Limited | 1.99% | 1.38% |
| Global Health Limited | 7.00% | 0.90% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 41.1% means 41.1% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Invesco India Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Manipal Health Enterprises Ltd | 7.98% |
| Dr Agarwals Health Care Limited | 6.32% |
| Corona Remedies Limited | 6.13% |
Largest holdings only in Mirae Asset Nifty 500 Healthcare ETF
| Security | % of fund |
|---|---|
| Laurus Labs Ltd. | 5.72% |
| Cipla Ltd. | 5.62% |
| Dr. Reddy's Laboratories Ltd. | 5.58% |
| Lupin Ltd. | 3.66% |
| Aurobindo Pharma Ltd. | 3.43% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Invesco India Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Equity | 87.0% | 100.0% |
| Debt | 0.0% | 0.0% |
| Cash and others | 13.0% | 0.0% |
Market cap of stocks
| Market cap | Invesco India Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Large Cap | 29.8% | 36.0% |
| Mid Cap | 16.4% | 45.6% |
| Small Cap | 32.8% | 18.3% |
| Not on AMFI's list | 8.0% | 0.0% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Invesco India Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Pharmaceuticals & Biotechnology | 41.4% | 77.8% |
| Healthcare Services | 45.6% | 21.7% |
| Healthcare Equipment & Supplies | 0.0% | 0.5% |
The six largest sectors of each fund's stocks, % of the fund.
Invesco India Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Invesco India Pharma and Healthcare Fund | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Total expense ratio (Direct) | 3.30% | Not available |
| Base expense ratio (Direct) | 0.50% | 0.00% |
| Total expense ratio (Regular) | 5.19% | Not available |
| Base expense ratio (Regular) | 2.10% | 0.16% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare Invesco India Pharma and Healthcare with
- Invesco India Pharma and Healthcare vs DSP Healthcare
- Invesco India Pharma and Healthcare vs Nippon India Pharma
- Invesco India Pharma and Healthcare vs Bandhan Transportation and Logistics
- Invesco India Pharma and Healthcare vs Nippon India Power & Infra
- Invesco India Pharma and Healthcare vs Invesco India Financial Services
Invesco India Pharma and Healthcare Fund vs Mirae Asset Nifty 500 Healthcare ETF: Frequently Asked Questions
What is the difference between Invesco India Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF?
Invesco India Pharma and Healthcare Fund is a Sectoral fund, Mirae Asset Nifty 500 Healthcare ETF is an ETF fund, run by Invesco Mutual Fund and Mirae Asset Mutual Fund. Their portfolios overlap 41.1%. Invesco India Pharma and Healthcare Fund charges 3.30% a year and Mirae Asset Nifty 500 Healthcare ETF 0.35%.
Which has the lower expense ratio, Invesco India Pharma and Healthcare Fund or Mirae Asset Nifty 500 Healthcare ETF?
Mirae Asset Nifty 500 Healthcare ETF charges less: 0.35% a year against 3.30%. These are the total expense ratios reported to AMFI.
How much do Invesco India Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF overlap?
41.1%. They hold 10 of the same securities, the largest shared ones being SUNPHARMA, DIVISLAB, APOLLOHOSP. From each fund's latest monthly portfolio.
Which is riskier, Invesco India Pharma and Healthcare Fund or Mirae Asset Nifty 500 Healthcare ETF?
On SEBI's riskometer, Invesco India Pharma and Healthcare Fund is rated Very High and Mirae Asset Nifty 500 Healthcare ETF Very High. Over their common history, the standard deviation of daily returns was 18.70% and 14.16% a year.
Can I invest in both Invesco India Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF?
Yes. 41.1% of each fund's money sits in the same holdings, so a large part of the two investments would move together.
Who manages Invesco India Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF?
Invesco India Pharma and Healthcare Fund: Aditya Khemani. Mirae Asset Nifty 500 Healthcare ETF: Ekta Gala, amp, Ritesh Patel.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.